Concepedia

Michel A. Steiner

MA

Statistics

Publications

25

Citations

1.7K

H-Index

20

Active since

1997

Affiliations

Actelion (Switzerland)(Current)

Max Planck Institute of Psychiatry

Idorsia (Switzerland)

Laboratoire des Sciences de l'Ingénieur, de l'Informatique et de l'Imagerie

Inserm

Michel A. Steiner is an author at Actelion (Switzerland) specializing in neuroscience, medicine, and neuropharmacology.

ORCID

Publications per year

1997–2024

25

Publications

25

ΔFosB in brain reward circuits mediates resilience to stress and antidepressant responses

Vincent Vialou, Alfred J. Robison, Quincey LaPlant et al. · Nature Neuroscience · 2010 · 481 citations

, , +14

Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior

Ailing Lu, Michel A. Steiner, Nigel Whittle et al. · Molecular Psychiatry · 2008 · 144 citations

, , +16

Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice

Michel A. Steiner, Giovanni Marsicano, Eric J. Nestler et al. · Psychoneuroendocrinology · 2007 · 141 citations · Full text

, , +13

Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice

Michel A. Steiner, Klaus Wanisch, Krisztina Monory et al. · The Pharmacogenomics Journal · 2007 · 122 citations

, , +13

Discovery and Characterization of ACT‐335827, an Orally Available, Brain Penetrant Orexin Receptor Type 1 Selective Antagonist

Michel A. Steiner, John Gatfield, Catherine Brisbare‐Roch et al. · ChemMedChem · 2013 · 95 citations

, , +17

1–5 of 25